1 of 45 _Page ,1~ #:150
`Case 8·11·,C'!'"00~61-JVS-~
`Document 27 Filed 09/19/11 ~e
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 1 of 25 Page ID #:202
`
`12
`~ o:l;
`...-~ 13
`o"'
`s -'°
`Q)
`;s= u.,;.~o
`-l C: (a!:; - 0 •
`- <i:cU:!:
`~...JO-':::'<t" ~-
`
`-~~
`~ V>~~o
`0
`.,...
`Ul
`i.. c:r--
`c.. u. ta '"'r..:.
`.......
`..JU.~
`OM
`
`i:l= 0
`
`·-
`
`w" ~::!:
`Q)
`s::l <.
`ow
`rJ)
`0.
`"'8
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`• . FILED-SOUTHERN DIVISION
`%; CLERK, U.S. DISTRICT COURT
`·~:
`
`SEP 2 0 2011
`
`Attorneys for Defendants and Counterclaim-Plaintiffs
`Edwards Lifesciences Corporation,
`Edwards Lifesciences LLC, and
`Edwards Lifesciences (U.S.) Inc.
`
`Attorneys for Counterclaim-Plaintiff
`Edwards Lifesciences PVT, Inc.
`
`UNITED STATES DISTRICT COURT
`
`CENTRAL DISTRICT OF CALIFORNIA, SANTA ANA
`
`CASE NO. SACVI 1-00961 JVS (MLGx)
`Hon. Joseph V. Selna
`Magistrate Judge Marc L. Goldman
`
`ANSWER AND COUNTERCLAIMS
`
`DEMAND FOR JURY TRIAL
`
`COMPLAINT FILED: June 27, 2011
`
`MEDTRONIC COREY AL VE LLC,
`MEDTRONIC CV LUXEMBOURG
`S.A.R.L., AND MEDTRONIC
`VASCULAR GALWAY LTD.,
`
`Plaintiffs,
`
`v.
`EDWARDS LIFESCIENCES
`CORPORATION, EDWARDS
`LIFESCIENCES LLC, AND
`EDWARDS LIFESCIENCES (U.S.)
`INC.,
`
`Defendants.
`
`Answer and Counterclaims
`Case No. SACVI 1-00961
`
`ENDOHEART AG, EX. 2024 Page 1
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·11.cv-00961-JVS -~41 ~ Document 27 Filed 09/19/11 ,e
`2 of 45 , Page.ID #:151
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 2 of 25 Page ID #:203
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`EDWARDS LIFESCIENCES
`CORPORATION, EDWARDS
`LIFESCIENCES LLC, EDWARDS
`LIFESCIENCES (U.S.) INC., AND
`EDWARDS LIFESCIENCES PVT,
`INC.,
`
`Counterclaim-Plaintiffs,
`
`V.
`
`MEDTRONIC COREY AL VE LLC,
`MEDTRONIC CV LUXEMBOURG
`S.A.R.L., MEDTRONIC
`VASCULAR GALWAY LTD.,
`MEDTRONIC, INC., AND
`MEDTRONIC VASCULAR, INC.
`
`Counterclaim-Defendants
`
`0~
`
`.~~
`
`12
`~ o"'
`...-~ 13
`s -"'
`<l)
`:-= ~~~8
`14
`~ u.,;.~o
`......... c:r--
`ll..U..
`.... ~
`- <a1U:!:
`I'll
`i'.;.Er--1
`o'd..JO---...-
`~-
`,_ju..
`- 0.
`15
`!;,: 0
`·-
`-1 s:: riC
`~" a;:.
`<l)
`s:::: <.
`o~
`r.n ~c3
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Defendants and Counterclaim-Plaintiffs Edwards Lifesciences Corporation,
`
`Edwards Lifesciences LLC ("Edwards LLC") and Edwards Lifesciences (U.S.) Inc.
`
`( collectively, "Edwards"), file this Answer and Counterclaims Counts I and II in
`
`response to Plaintiffs Medtronic Core Valve LLC, Medtronic CV Luxembourg
`
`S.a.r.l. and Medtronic Vascular Galway Ltd. (collectively, "Medtronic Plaintiffs")
`
`Complaint for Patent Infringement (hereinafter, "the Complaint"), and
`
`Counterclaim-Plaintiffs Edwards LLC and Edwards Lifesciences PVT, Inc.
`
`("Edwards PVT") file Counterclaim Count III for infringement of United States
`
`Patent No. 8,002,825 by the Medtronic entities as hereinafter stated.
`
`ANSWER
`
`INTRODUCTION
`
`1.
`
`Edwards admits only that the Complaint purports to bring an action for
`
`patent infringement.
`
`2.
`
`Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 2 of the Complaint, and
`
`- 2 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 2
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·1 t-cv-00961-JVS -~· ~ Document 27 Filed 09/19/11 ~e
`3 of 45 , Page.ID #:152
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 3 of 25 Page ID #:204
`
`~ oll;
`.,.,_
`o"'
`Q)
`
`s -'°
`
`.~~
`:;::: ~a~g
`~ U-o-~o
`g.; u: ~ E~
`...J U.. t..E r-.1
`da...J0"3;'<t'°
`~ 0
`.-
`·-
`<"'U::!;
`.-
`,....lc::rdC
`0
`•
`~ u a;:.
`Q)
`s:::: <.
`o~
`S5c§
`rJ)
`
`1
`
`accordingly those allegations are denied.
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`3.
`
`Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 3 of the Complaint, and
`
`accordingly those allegations are denied.
`
`4.
`
`Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 4 of the Complaint, and
`
`accordingly those allegations are denied.
`
`5.
`
`6.
`
`7.
`
`Edwards admits the allegations of Paragraph 5 of the Complaint.
`
`Edwards admits the allegations of Paragraph 6 of the Complaint.
`
`Edwards admits the allegations of Paragraph 7 of the Complaint.
`
`JURISDICTION AND VENUE
`
`8.
`
`Edwards admits only that the Medtronic Plaintiffs purport to invoke
`
`the jurisdiction of this Court pursuant to 28 U.S.C. §§ 1331 and 1338(a).
`
`9.
`
`Edwards admits only that venue in this District is proper.
`
`10. Edwards admits only that this Court has personal jurisdiction over
`
`each of the named Defendants. Edwards denies every other allegation of Paragraph
`
`10.
`
`FACTUAL BACKGROUND
`
`11. Edwards admits that United States Patent No. 7,892,281 ("the Seguin
`
`'281 patent") was issued on February 22, 2011, is entitled "Prosthetic Valve for
`
`Transluminal Delivery," and that a copy of the Seguin '281 patent is attached to the
`
`Complaint as "Exhibit 1." Edwards denies the remaining allegations of Paragraph
`
`11 of the Complaint.
`
`12. Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 12 of the Complaint, and
`
`accordingly those allegations are denied.
`
`13. Edwards is without knowledge or information sufficient to form a
`
`- 3 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 3
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·11,..cv-00961-JVS -ri-~· G Document 27 Filed 09/19/11 ~~e 4 of 45 , Page,ID #:153
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 4 of 25 Page ID #:205
`
`1
`
`belief as to the truth of the allegations of Paragraph 13 of the Complaint, and
`
`S,..!
`Cl)
`
`og;
`s -.;,
`O,o
`""-
`-~~
`VJ~~o
`,....,i
`•...-1
`W
`0
`~ u.,;.~o
`- <"'U;!
`........
`i:: r-
`c..: u. nl
`... ~
`,_.jU.. r;..Er-1
`da-i 0-;:.=~
`- 0
`el: 0
`·-
`..it:
`..Ji::
`•
`~ V ~::.
`s:: <.
`o~
`~ o" "'c3
`
`Cl)
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`accordingly those allegations are denied.
`
`14. Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 14 of the Complaint, and
`
`accordingly those allegations are denied.
`
`15. Edwards is without knowledge or information sufficient to form a
`
`belief as to the truth of the allegations of Paragraph 15 of the Complaint, and
`
`accordingly those allegations are denied.
`
`COUNT 1
`
`16. Edwards restates, realleges and incorporates by reference its responses
`
`to the allegations set forth in Paragraphs 1 through 15.
`
`1 7. Edwards denies the allegations of Paragraph 1 7 of the Complaint.
`
`18. Edwards denies the allegations of Paragraph 18 of the Complaint.
`
`19. Edwards denies the allegations of Paragraph 19 of the Complaint.
`
`20.
`
`21.
`
`Edwards denies the allegations of Paragraph 20 of the Complaint.
`
`Edwards denies the allegations of Paragraph 21 of the Complaint.
`
`AFFIRMATIVE DEFENSES
`
`First Affirmative Defense (Failure to State a Claim)
`
`22. Medtronic Plaintiffs' Complaint fails to state a claim upon which relief
`
`can be granted.
`
`Second Affirmative Defense (Noninfringement)
`
`23.
`
`Edwards has not infringed, contributorily infringed or actively induced
`
`the infringement of any valid claim of the Seguin '281 patent, either literally or
`
`under the doctrine of equivalents, and does not do so now.
`
`Third Affirmative Defense (Invalidity)
`
`24.
`
`Edwards is informed and believes, and thereupon alleges, that the
`
`Seguin '281 patent is invalid for failure to meet one or more of the requirements of
`
`- 4 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 4
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·1 t-cv-00961-JVS -P 1
`Document 27 Filed 09/19/11 n'\ge 5 of 45. Page_lD #:154
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 5 of 25 Page ID #:206
`
`·~
`
`s -'°
`
`~ 0~
`0-c,
`"',-
`Q.)
`.~~
`~ ~~~g
`~ u.,;.~o
`~ii::; E~
`....JU.. ~,EN
`~..JO---..- ~-
`P'Ju~
`w u •::.
`Q.)
`s:: <~
`ow
`r:n
`0~ -oJ
`
`- :s i:: ci~ - 0 ~
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`patentability under United States Code Title 35, including, without limitation, one
`
`or more of the requirements of 35 U.S.C. §§ 102, 103 and/or 112.
`
`Additional Affirmative Defenses
`
`25. Edwards expressly reserves the right to assert and pursue additional
`
`defenses resulting from discovery and/or Edwards' ongoing investigations.
`
`PRAYER FOR RELIEF
`
`WHEREFORE, Edwards prays for relief as follows:
`
`A.
`
`That the Court enter judgment in favor of Edwards, and against
`
`Medtronic Plaintiffs;
`
`B.
`
`That the Court enter judgment that Edwards has not infringed the
`
`Seguin '281 patent, either literally or under the doctrine of equivalents;
`
`C.
`
`D.
`
`That the Court enter judgment that the Seguin '281 patent is invalid;
`
`That the Court deny any and all of Medtronic Plaintiffs' requests for
`
`injunctive relief;
`
`E.
`
`That the Court dismiss Medtronic Plaintiffs' Complaint in its entirety,
`
`with prejudice;
`
`F.
`
`That the Court find this case exceptional under 35 U.S.C. § 285, and
`
`award Edwards its reasonable attorneys' fees, costs and disbursements; and
`
`G.
`
`That the Court grant Edwards such other relief as the Court deems just
`
`and proper.
`
`Edwards demands a trial by jury on all issues so triable in the Complaint.
`
`JURY DEMAND
`
`- 5 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 5
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·11,~cv-00961-JVS -t-•· q Document 27 Filed 09/19/11
`'"'"'ge 6 of 45 , Page.ID #:155
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 6 of 25 Page ID #:207
`
`oll;
`o"'
`"'"-
`-'°
`13
`8
`.~~
`.......-4 <n~~o
`p.; u:; =~
`......
`W
`0
`14
`~ u.,;.~o
`- -( -
`dd ,_j 0-;.=~ ~.zu;;: 15
`..Ju. ~,21"1
`- 0.
`16
`
`J-4
`Q)
`
`....I£:: ti!:-
`~ u o::;
`Q)
`~ <~
`o~
`o•
`VJ
`"'8
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`COUNTERCLAIMS
`
`INTRODUCTION
`
`1.
`
`These Counterclaims are for declaratory relief with respect to the
`
`Seguin '281 patent (Counts I and II), and for willful infringement of United States
`
`Patent 8,002,825 ("the Cribier '825 patent") owned and licensed by Edwards PVT
`
`and Edwards LLC as hereinafter stated ( Count III). These Counterclaims arise
`
`under the patent laws of the United States, 35 U.S.C. § 101 et seq., and the
`
`Declaratory Judgment Act, 28 U.S.C. §§ 2201 and 2202.
`
`JURISDICTION AND VENUE
`
`2.
`
`The Court has subject matter jurisdiction over these Counterclaims
`
`pursuant to 28 U.S.C. §§ 1331, 1338, and 1367.
`
`3.
`
`Venue in this District is proper pursuant to 28 U.S.C. §§ 139l(b), (c),
`
`and ( d), and 1400 (b ).
`
`4.
`
`Counterclaim-Plaintiffs Edwards Lifesciences Corporation, Edwards
`
`LLC, Edwards Lifesciences (U.S.) Inc. and Edwards PVT are each organized and
`
`existing under the laws of Delaware, with their principal places of business in
`
`Irvine, California.
`
`5.
`
`Upon information and belief, Counterclaim-Defendant Medtronic
`
`Core Valve LLC is a limited liability corporation organized and existing under the
`
`laws of Delaware, with its principal place of business in Irvine, California.
`
`6.
`
`Upon information and belief, Counterclaim-Defendant Medtronic CV
`
`Luxembourg S.a.r.l. is a limited liability company organized and existing under the
`
`laws of Luxembourg, with its principal place of business in Luxembourg. Upon
`
`information and belief, Medtronic CV Luxembourg S.a.r.l. is subject to the
`
`jurisdiction of this Court, inter alia, by virtue of invoking the jurisdiction of this
`
`Court by filing this action, and by doing business in this District.
`
`7.
`
`Upon information and belief, Counterclaim-Defendant Medtronic
`
`- 6 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 6
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·11.-cv-00961-JVS -~·0 ~ Document 27 Filed 09/19/11 n"9e 7 of 45, Page.ID #:156
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 7 of 25 Page ID #:208
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`f-1
`(1)
`
`o°'
`0~
`
`12
`..-~ 13
`s -"'
`.~~
`;s: U-o-~o
`:-;:1 ~~~g
`14
`ii; u: ~ e~
`~jo-H'.i
`~ 0 ·-
`...... :s C: it;
`'°U:!;
`...... 0.
`~" c:;:.
`(1)
`s::: <.
`r.n
`o~
`0. "'c3
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Vascular Galway Ltd. is a company organized and existing under the laws of
`
`Ireland, with its principal place of business in Galway, Ireland. Upon information
`
`and belief, Medtronic Vascular is subject to the jurisdiction of this Court, inter alia,
`
`by virtue of invoking the jurisdiction of this Court by filing this action, and by
`
`doing business in this District.
`
`8.
`
`Upon information and belief, Counterclaim-Defendant Medtronic, Inc.
`
`is a corporation organized and existing under the laws of the state of Minnesota and
`
`having its principal place of business in Minneapolis, Minnesota. Upon
`
`information and belief, Medtronic, Inc. is subject to the jurisdiction of this Court,
`
`inter alia, by doing business in this District.
`
`9.
`
`Upon information and belief, Counterclaim-Defendant Medtronic
`
`Vascular, Inc. is a corporation organized and existing under the laws of the state of
`
`Delaware and having its principal place of business in Santa Rosa, California.
`
`Upon information and belief, Medtronic Vascular, Inc. is subject to the jurisdiction
`
`of this Court, inter alia, by doing business in this District.
`
`COUNT I
`
`DECLARATORY JUDGMENT OF
`
`NONINFRINGEMENT OF THE SEGUIN '281 PATENT
`
`10. Edwards restates, realleges and incorporates by reference the
`
`allegations made in the Affirmative Defenses and in Paragraphs 1-9 of the
`
`Counterclaims above.
`
`11. An actual controversy exists between Edwards and Counter-
`
`Defendants Medtronic Core Valve LLC, Medtronic CV Luxembourg S.a.r.l. and
`
`Medtronic Vascular Galway Ltd. over the alleged infringement of the Seguin '281
`
`patent.
`
`12. Edwards has not infringed, contributorily infringed or actively induced
`
`the infringement of any valid claim of the Seguin '281 patent, either literally or
`
`- 7 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 7
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·1 t-cv-00961-JVS -~"'"'~ Document 27 Filed 09/19/11 '"'~e 8 of 45, Page,ID #:157
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 8 of 25 Page ID #:209
`
`1
`
`under the doctrine of equivalents.
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`13. Edwards has not willfully infringed, contributorily infringed or
`
`actively induced the infringement of any valid claim of the Seguin '281 patent,
`
`either literally or under the doctrine of equivalents.
`
`COUNT II
`
`DECLARATORY
`
`JUDGMENT OF
`
`INVALIDITY OF THE SEGUIN '281 PATENT
`
`14. Edwards restates, realleges and incorporates by reference the
`
`allegations made in its Affirmative Defenses and in Paragraphs 1-13 of Edwards'
`
`Counterclaims above.
`
`15. An actual controversy exists between Edwards and Counterclaim-
`
`Defendants Medtronic Core Valve LLC, Medtronic CV Luxembourg S.a.r.l. and
`
`Medtronic Vascular Galway Ltd. over the invalidity of the Seguin '281 patent.
`
`16. All claims of the Seguin '281 patent are invalid because they fail to
`
`comply with one or more requirements of United States Code Title 35, including,
`
`without limitation, one or more requirements of 35 U.S.C. §§ 102, 103 and/or 112.
`
`COUNT III
`
`INFRINGEMENT OF THE CRIBIER
`
`'825 PATENT
`
`17. Counterclaim-Plaintiffs Edwards LLC and Edwards PVT restate,
`
`reallege and incorporate by reference the allegations of Paragraphs 1-16 above.
`
`18. On August 23, 2011, the Cribier '825 patent (Exhibit A hereto),
`
`entitled "Implantable Prosthetic Valve for Treating Aortic Stenosis," was duly and
`
`legally issued and names Alain Cribier and Brice Letac as inventors. Counterclaim(cid:173)
`
`Plaintiff Edwards PVT is the assignee of the Cribier '825 patent, and Counterclaim(cid:173)
`
`Plaintiff Edwards LLC is the exclusive licensee of the Cribier '825 patent for the
`
`field of all cardiovascular applications, including the right to sue and recover for
`
`any and all past infringement thereof in the field of all cardiovascular applications.
`
`- 8 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`1-1
`Q)
`
`0~
`O-o
`
`[lJ
`
`0
`
`,.ju.
`
`Q)
`
`.,.,_
`s -'°
`-~~
`.....-4 U'lci!~o
`;s:: u.,;.~o
`•...-4
`14
`~ ~:; e;:::
`- 0 ~
`- <
`t.21"1
`&d ...i 0-::;::""
`~JJ;:;: 15
`-
`...Jr:: ni!::;
`w u
`s:: <.
`<::E
`ow
`rJ') ~8
`
`ENDOHEART AG, EX. 2024 Page 8
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8·11,-cv-OQ.961-JVS --~ ~·~ Document 27 Filed 09/19/11 ,...."'{Je 9 of 45. Page, ID #:158
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 9 of 25 Page ID #:210
`
`.... - 13
`s -_;,
`·'= '°
`=-= gJ~~g
`~ u,,;.~o
`,:i.; u: ~ e~
`- <"'U:!;
`..JU.~.El"I
`.....JCci~ - 0.
`O;;~v
`~ 0
`·-
`
`~ 0~
`Oso
`Q)
`
`UN
`
`~..J
`
`~ u ""
`Q)
`s:::: <.
`o~
`r.n 0. "'c3
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`19. Upon information and belief, and in violation of 35 U.S.C. § 271,
`
`Medtronic Core Valve LLC, Medtronic CV Luxembourg S.a.r.1., Medtronic
`
`Vascular Galway Ltd., Medtronic, Inc. and/or Medtronic Vascular, Inc. have been
`
`and are now infringing the Cribier '825 patent by manufacturing, using, importing,
`
`selling, offering to sell and/or supplying heart valve prostheses covered by one of
`
`more claims of the Cribier '825 patent, including without limitation products
`
`designated as the Generation 3 Re Valving system.
`
`20. Upon information and belief, and in violation of 35 U.S.C. § 271,
`
`Medtronic CV Luxembourg S.a.r.l., Medtronic Vascular Galway Ltd., Medtronic,
`
`Inc. and/or Medtronic Vascular, Inc. had knowledge of the Cribier '825 patent, and
`
`have acted with specific intent to actively induce Medtronic Core Valve LLC to
`
`directly infringe the Cribier '825 patent by, inter alia, manufacturing the
`
`Generation 3 Re Valving system.
`
`21. Upon information and belief, and in violation of 35 U.S.C. § 271,
`
`Medtronic CV Luxembourg S.a.r.l., Medtronic Vascular Galway Ltd., Medtronic,
`
`Inc., and/or Medtronic Vascular, Inc. have contributorily infringed the Cribier '825
`
`patent by supplying components constituting a material part of the invention
`
`claimed in the Cribier '825 patent, knowing the same to be especially made or
`
`especially adapted for infringement of the Cribier '825 patent, and not a staple
`
`article or commodity of commerce suitable for substantial non-infringing use,
`
`including without limitation infringement by virtue of Medtronic CoreValve LLC's
`
`manufacture of the Generation 3 Re Valving system.
`
`22.
`
`The foregoing infringement has been willful and deliberate, rendering
`
`this case exceptional within the meaning of 35 U.S.C. § 285.
`
`23. Counterclaim-Plaintiffs Edwards PVT and Edwards LLC have been
`
`damaged and will be irreparably injured by the foregoing continuing infringement,
`
`for which Edwards PVT and Edwards LLC have no adequate remedy at law. These
`
`- 9 -
`
`Answer and Counterclaims
`Case No. SACVI 1-00961
`
`ENDOHEART AG, EX. 2024 Page 9
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Cas 8;11-cv-00961-JV9 ~.LG Document 27 Filed 09/19/1" Page 10 of.45 Page ID
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 10 of 25 Page ID #:211
`#:159
`
`1
`
`infringing activities will continue unless enjoined by this Court.
`
`0~
`
`s -'°
`
`~ o°'
`..-~
`Q)
`.~~
`,.....c U)~6!o
`0
`,,,...
`Ul
`~ U--o-~O
`i:i..: u: ~ E~
`..ju.. > 01'1
`o?j ...J o~::;"r
`~,gJ~
`.-
`<
`-
`.-
`..Ji::ci~
`0 ~
`~ u •::.
`Q)
`~ <" o~
`rfJ
`'° c3
`
`0~
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`ADDITIONAL COUNTERCLAIMS
`
`Each and all of the Counterclaim-Plaintiffs reserve the right to assert and
`
`pursue additional counterclaims resulting from discovery and the Counterclaim(cid:173)
`
`Plaintiffs' ongoing investigations.
`
`PRAYER FOR RELIEF
`
`WHEREFORE, Counterclaim-Plaintiffs Edwards and Edwards PVT pray for
`
`relief as follows:
`
`A.
`
`That the Court enter judgment that Edwards has not infringed the
`
`Seguin'281 patent, either literally or under the doctrines of equivalents;
`
`B.
`
`C.
`
`That the Court enter judgment that the Seguin '281 patent is invalid;
`
`That the Court enter judgment that Medtronic Core Valve LLC,
`
`Medtronic CV Luxembourg S.a.r.l., Medtronic Vascular Galway Ltd., Medtronic,
`
`Inc. and Medtronic Vascular, Inc. have infringed, contributorily infringed and/or
`
`actively induced the infringement of the Cribier '825 patent;
`
`D.
`
`That the Court enter judgment that the foregoing infringement by
`
`Medtronic Core Valve LLC, Medtronic CV Luxembourg S.a.r.l., Medtronic
`
`Vascular Galway Ltd., Medtronic, Inc. and Medtronic Vascular, Inc. has been
`
`willful and deliberate;
`
`E.
`
`That the Court enter an order permanently enjoining and restraining
`
`Medtronic Core Valve LLC, Medtronic CV Luxembourg S.a.r.l., Medtronic
`
`Vascular Galway Ltd., Medtronic, Inc. and Medtronic Vascular, Inc., their officers,
`
`agents, servants, employees and attorneys, all parent, subsidiary and affiliate
`
`corporations and other related business entities, and all other persons or entities
`
`acting in concert, participation or in privity with one or more of them, and their
`
`successors and assigns, from infringing, contributing to the infringement of, or
`
`actively inducing others to infringe the Cribier '825 patent;
`
`- 10 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 10
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Cas 8:11-cv-00961-JV~ ~LG Document 27 Filed 09/19/1,t Page 11 of.45 Pf.lge ID
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 11 of 25 Page ID #:212
`#:160
`
`~ 0~
`O-o
`Q.)
`
`~
`
`......
`s ~'°
`u~,
`.!:!so
`~ ~~~g
`~ u.,;.~o
`-
`... c:r--
`... r:,.
`~u..
`ta
`- <
`Jd .Jo~:;"'"
`..JU..> Or--1
`...JC:ci~ - 0.
`~JU-;;
`
`Q.)
`
`w u o::;
`s:: < ~
`ow
`r:r.J
`o•
`"'8
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`F.
`
`That the Court award Edwards PVT and Edwards LLC damages, in an
`
`amount to be determined at trial, together with interest and costs as fixed by the
`
`Court;
`
`G.
`That the Court award Edwards PVT and Edwards LLC enhanced
`damages under 35 U.S.C. § 284;
`
`H.
`That the Court award Edwards and Edwards PVT their reasonable
`attorneys' fees and their costs and disbursements in this action, as provided by 35
`U.S.C. § 285; and
`I.
`
`That the Court grant Edwards and Edwards PVT such other relief as
`
`the Court deems just and proper.
`
`Edwards and Edwards PVT demand a trial by jury on all issues so triable in
`
`JURY DEMAND
`
`its Counterclaims.
`Dated: September 19, 2011
`
`SNELL & WILMER L.L.P
`William S. O'Hare
`Deborah S. Mallgrave
`
`PAUL WEISS RIFKIND WHARTON &
`GARRISON L.L.P.
`John E. Nathan (pro hac vice)
`Catherine Nyarady (pro hac vice)
`Brian P. Egan (pro hac vice)
`
`By:
`
`s/ Deborah S. Mallgrave
`Deborah S. Mallgrave
`Attorneys for Defendants and
`Counterclaim-Plaintiffs
`Edwards Lifesciences Corporation,
`Edwards Lifesciences LLC, and
`-Edwards Lifesciences (U.S.) Inc.
`
`Attorneys for Counterclaim-Plaintiff
`Edwards Lifesciences PVT, Inc.
`
`- 11 -
`
`Answer and Counterclaims
`Case No. SACVl 1-00961
`
`ENDOHEART AG, EX. 2024 Page 11
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8~11-cv-.00961-JV$ "1,LG Document 27 Filed 09/19/11 Page 12 of.45 Ppge ID
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 12 of 25 Page ID #:213
`#:161
`
`Exhibit A
`
`-12 -
`
`Exhibit A
`
`ENDOHEART AG, EX. 2024 Page 12
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8:11-cv-.00961-JVP .. -4LG Document 27 Filed 09/19/i-'- Page 13 of.45 Page ID
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 13 of 25 Page ID #:214
`#:162
`
`I IIIII IIIIIIII Ill lllll lllll lllll lllll lllll lllll lllll lllll 111111111111111111
`US008002825B2
`
`(12) United States Patent
`Letac et al.
`
`(10) Patent No.:
`(45) Date of Patent:
`
`US 8,002,825 B2
`* Aug. 23, 2011
`
`(54)
`
`IMPLANTABLE PROSTHETIC VALVE FOR
`TREATING AORTIC STENOSIS
`
`(75)
`
`Inventors: Brice Letac, Mont-Saint-Aigan (FR);
`Alain Crlbler, Pavilly (FR)
`
`(73)
`
`Assignee: Edwards Lifesciences PVT, Inc., Irvine,
`CA(US)
`
`( *)
`
`Notice:
`
`Subject to any disclaimer, the term of this
`patent is extended or adjusted under 35
`U.S.C. 154(b) by O days.
`
`This patent is subject to a terminal dis(cid:173)
`claimer.
`
`(21) Appl. No.: 12/915,538
`
`(22) Filed:
`
`Oct. 29, 2010
`
`(65)
`
`Prior Publication Data
`
`US 2011/0040375 Al
`
`Feb. 17, 2011
`
`Related U.S. Application Data
`
`(63) Continuation of application No. 11/942,690, filed on
`Nov. 19, 2007, now Pat. No. 7,846,204, which is a
`continuation of application No. 11/110,402, filed on
`Apr. 20, 2005, now abandoned, which is a continuation
`of application No. 10/139,741, filed on May 2, 2002,
`now Pat. No. 6,908,481, which is a continuation of
`application No. 09/795,803, filed on Feb. 28, 2001,
`now abandoned, which is a continuation of application
`No. 09/345,824,
`filed on Jun. 30, 1999, now
`abandoned, which is a continuation of application No.
`PCT/EP97/07337,.filed on Dec. 13, 1997.
`
`(30)
`
`Foreign Application Priority Data
`
`Dec. 31, 1996
`
`(EP) ..................................... 96402929
`
`(51)
`
`Int. Cl.
`A61F 2124
`(2006.01)
`(52) U.S. CI .
`....................... 623/2.14; 623/2.17; 623/900
`
`(58) Field of Classification Search ................. 623/2.14,
`623/2.17, 900, 1.26, 2.12
`See application file for complete search history.
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`3,409,013 A
`11/1968 Beny
`(Continued)
`
`DE
`
`FOREIGN PATENT DOCUMENTS
`2246526
`3/1973
`(Continued)
`
`OTHER PUBLICATIONS
`
`Andersen et al., "Transluminal implantation of artificial heart valves.
`Description of a new expandable aortic valve and initial results with
`implantation by catheter technique in closed chest pigs." European
`Heart Journal (1992) 13, pp. 704-708.
`
`(Continued)
`
`Primary Examiner - Brian Pellegrino
`(74) Attomey, Agent, or Firm - David L. Hauser
`
`ABSTRACT
`(57)
`A prosthetic valve for implantation in a stenosed aortic valve.
`The prosthetic valve includes a compressible and expandable
`frame formed with intersecting metallic bars and a valvular
`structure made with pericardia! tissue. The frame is com(cid:173)
`pressible for delivery into a patient's vasculature through an
`18 F (5.7 mm) arterial introducer using a catheterization
`technique. The bars of the frame preferably have a diameter in
`the range of 0.1 to 0.6 mm for providing the frame with
`sufficient radial strength to resist the recoil force exerted by
`the stenosed aortic valve after implantation. The prosthetic
`valve includes an internal cover made with pericardia! tissue.
`The internal cover is fastened to an internal surface of the
`frame between an inlet end of the frame and the valvular
`structure for preventing regurgitation.
`
`20 Claims, 18 Drawing Sheets
`
`19
`
`-13 -
`
`Exhibit A
`
`ENDOHEART AG, EX. 2024 Page 13
`EDWARDS LIFESCIENCES CORPORATION (PETITIONER) v. ENDOHEART AG (PATENT OWNER)
`Case No.: IPR2016-00300, U.S Patent No. 8,182,530
`
`

`
`Case 8:11-cv-00961-JV$ 'ALG Document 27 Filed 09/19/t-i Page 14 of.45 P?ge ID
`Case 8:11-cv-00961-JVS-MLG Document 30 Filed 09/20/11 Page 14 of 25 Page ID #:215
`#:163
`
`US 8,002,825 B2
`Page2
`
`U.S. PATENT DOCUMENTS
`3,548,417 A
`12/1970 Ki sher
`3,587,115 A
`6/1971 Shiley
`3,657,744 A
`4/1972 Ersek
`3,671,979 A
`6/1972 Moulopoulos
`3,714,671 A
`2/1973 Edwards et al.
`3,755,823 A
`9/1973 Hancock
`4,035,849 A
`7/1977 Angell etal.
`4,056,854 A
`11/1977 Boretos et al.
`4,106,129 A
`8/1978 Carpentier et al.
`4,222,126 A
`9/1980 Boretos et al.
`4,265,694 A
`5/1981 Boretos et al.
`4,297,749 A
`11/1981 Davis et al.
`4,339,831 A
`7/1982 Johnson
`4,343,048 A
`8/1982 Ross etal.
`4,345,340 A
`8/1982 Rosen
`4,373,216 A
`2/1983 Klawitter
`9/1983 Roy
`4,406,022 A
`4,470,157 A
`9/]984 Love
`8/1985 Klawitter et al.
`4,535,483 A
`4,574,803 A
`3/1986 Storz
`4,592,340 A
`6/1986 Boyles
`4,605,407 A
`8/1986 Black eta!.
`4,612,011 A
`9/1986 Kautzky
`4,629,459 A
`12/1986 Ionescu et al.
`4,643,732 A
`2/1987 Pietsch et al.
`4,655,771 A
`4/1987 Wallsten
`4,687,483 A
`8/1987 Fisher et al.
`4,692,164 A
`9/1987 Dzemeshkevich et al.
`4,733,665 A
`3/1988 Palmaz
`4,759,758 A
`7/1988 Gabbay
`4,777,951 A
`10/1988 Cribier et al.
`11/1988 Lazarus
`4,787,899 A
`11/1988 Baykut
`4,787,901 A
`4,796,629 A
`1/1989 Grayzel
`5/1989 Thuroffet al.
`4,829,990 A
`4,851,001 A
`7/1989 Taheri
`8/1989 Hillstead
`4,856,516 A
`11/1989 Grayzel
`4,878,495 A
`11/1989 Lindermann et al.
`4,878,906 A
`11/1989 Shiber
`4,883,458 A
`5/1990 Strecker
`4,922,905 A
`10/1990 Reiss
`4,966,604 A
`12/1990 Shiber
`4,979,939 A
`1/1991 Owens et al.
`4,986,830 A
`2/1991 Dobben
`4,994,077 A
`5,007,896 A
`4/1991 Shiber
`5,026,366 A
`6/1991 Leckrone
`7/1991 Alonso
`5,032,128 A
`8/1991 Lane
`5,037,434 A
`9/1991 Sammuels
`5,047,041 A
`5,080,668 A
`1/1992 Bolz et al.
`2/1992 Cragg
`5,085,635 A
`2/1992 Ross
`5,089,015 A
`10/199.2 Sabbaghian et al.
`5,152,771 A
`11/1992 Vince
`5,163,953 A
`12/1992 Boyles
`5,167,628 A
`2/1994 Trescony et al.
`5,282,847 A
`3/1994 Shturman
`5,295,958 A
`7/1994 Teitelbaum
`5,332,402 A
`5,360,444 A
`11/1994 Kusuhara
`12/1994 Stevens
`5,370,685 A
`3/1995 Pavcnik et al.
`5,397,351 A
`5/1995 Anderson et al.
`5,411,055 A
`5/1995 Anderson et al.
`5,411,552 A
`5,443,446 A
`8/1995 Shturman
`5,480,424 A
`1/1996 Cox
`3/1996 Quijano et al.
`5,500,014 A
`8/1996 Roberts et al.
`5,545,209 A
`8/1996 Stevens
`5,545,214 A
`8/1996 Vesely
`5,549,665 A
`9/1996 Block et al.
`5,554,185 A
`11/1996 Vanney et al.
`5,571,175 A
`5,591,185 A
`1/1997 Kilmer et al.
`3/1997 Trescony et al.
`5,607,464 A
`
`3/1997 Quijano et al.
`5,609,626 A
`2/1998 Girard et al.
`5,716,417 A
`3/1998 Leone et al.
`5,728,068 A
`5/1998 Shalcnovich
`5,749,890 A
`5/1998 Epstein
`5,756,476 A
`10/1998 Fogarty et al.
`5,824,037 A
`11/1998 Andersen et al.
`5,840,081 A
`1/1999 Jayaraman
`5,855,597 A
`1/1999 Bessler
`5,855,601 A
`1/1999 Angell
`5,855,602 A
`112001 Andersen et al.
`6,168,614 Bl
`6/2003 Andersen et al.
`6,582,462 Bl
`6/2005 Cribier
`6,908,481 B2
`9/2009 Cribier
`7,585,321 B2
`11/2009 Andersen et al.
`7,618,446 B2
`9/2010 Andersen et al.
`7,789,909 B2
`7,846,204 B2 • 12/2010 Letac et al ................... 623/2.15
`7/2001 Letac et al.
`2001/0007956 A I
`7/2001 Letac et al.
`2001/0010017 Al
`6/2003 Cribier
`2003/0 I 09924 A I
`9/2005 Cribier
`2005/0203616 Al
`1/2008 Cribier
`2008/0009940 A I
`3/2008 Letac eta!.
`2008/0077236 A I
`
`DE
`DE
`EP
`EP
`EP
`GB
`GB
`SU
`SU
`SU
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`
`FOREIGN PATENT DOCUMENTS
`3/1997
`19532846
`6/1997
`19546692
`3/1984
`0103546
`6/1985
`0144167
`0592410
`11/1991
`1268484
`3/1972
`3/1981
`2056023
`5/1964
`158988
`1271508
`11/1986
`1371700
`2/1988
`W091/17720
`11/1991
`10/1992
`W092/17118
`2/1993
`W093/01768
`W094/12136
`6/1994
`W096/40008
`12/1996
`7